Pathogenesis and Treatment of ANCA-associated Systemic Vasculitis

Overview

Journal J R Soc Med

Specialty General Medicine

Date 2000 Jan 25

PMID 10645294

Citations 1

Authors

A D Salama

Affiliations

Soon will be listed here.

Citing Articles

Unravelling the Link between the Gut Microbiome and Autoimmune Kidney Diseases: A Potential New Therapeutic Approach.

Tan D, Akelew Y, Snelson M, Nguyen J, OSullivan K Int J Mol Sci. 2024; 25(9).

PMID: 38732038 PMC: 11084259. DOI: 10.3390/ijms25094817.

References

Reumaux D, Vossebeld P, Roos D, Verhoeven A . Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood. 1995; 86(8):3189-95. View

Simpson I, Skinner M, Geursen A, Peake J, Abbott W, Fraser J . Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor V beta 2 gene usage in microscopic polyarteritis. Clin Exp Immunol. 1995; 101(2):220-6. PMC: 1553271. DOI: 10.1111/j.1365-2249.1995.tb08342.x. View

Stegeman C, Tervaert J, de Jong P, Kallenberg C . Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996; 335(1):16-20. DOI: 10.1056/NEJM199607043350103. View

GRIFFITH M, Lovegrove J, Gaskin G, Whitehouse D, Pusey C . C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant. 1996; 11(3):438-43. View

Gilligan H, Bredy B, Brady H, Hebert M, Slayter H, Xu Y . Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med. 1996; 184(6):2231-41. PMC: 2196384. DOI: 10.1084/jem.184.6.2231. View

Lockwood C, Thiru S, Stewart S, Hale G, Isaacs J, Wraight P . Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies. QJM. 1996; 89(12):903-12. DOI: 10.1093/qjmed/89.12.903. View

Savage C, Harper L, Adu D . Primary systemic vasculitis. Lancet. 1997; 349(9051):553-8. DOI: 10.1016/s0140-6736(97)80118-3. View

Exley A, Carruthers D, Luqmani R, Kitas G, Gordon C, Janssen B . Damage occurs early in systemic vasculitis and is an index of outcome. QJM. 1997; 90(6):391-9. DOI: 10.1093/qjmed/90.6.391. View

Jayne D, Rasmussen N . Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc. 1997; 72(8):737-47. DOI: 10.1016/S0025-6196(11)63594-5. View

10.

Jennette J, Falk R . Small-vessel vasculitis. N Engl J Med. 1997; 337(21):1512-23. DOI: 10.1056/NEJM199711203372106. View

11.

Heeringa P, Brouwer E, Tervaert J, Weening J, Kallenberg C . Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int. 1998; 53(2):253-63. DOI: 10.1046/j.1523-1755.1998.00743.x. View

12.

Sibelius U, Hattar K, Schenkel A, Noll T, Csernok E, Gross W . Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response. J Exp Med. 1998; 187(4):497-503. PMC: 2212153. DOI: 10.1084/jem.187.4.497. View

13.

GRIFFITH M, Pusey C . HLA genes in ANCA-associated vasculitides. Exp Clin Immunogenet. 1997; 14(3):196-205. View

14.

Ludviksson B, Sneller M, Chua K, Talar-Williams C, Langford C, Ehrhardt R . Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol. 1998; 160(7):3602-9. View

15.

Allen A, Pusey C, Gaskin G . Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol. 1998; 9(7):1258-63. DOI: 10.1681/ASN.V971258. View

16.

Pinching A, Rees A, Pussell B, Lockwood C, Mitchison R, PETERS D . Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980; 281(6244):836-8. PMC: 1714254. DOI: 10.1136/bmj.281.6244.836. View

17.

Fauci A, Haynes B, Katz P, Wolff S . Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983; 98(1):76-85. DOI: 10.7326/0003-4819-98-1-76. View

18.

Tervaert J, Huitema M, Hene R, Sluiter W, The T, VAN DER HEM G . Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990; 336(8717):709-11. DOI: 10.1016/0140-6736(90)92205-v. View

19.

Sitara D, Hoffbrand B . Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis. Postgrad Med J. 1990; 66(778):669-71. PMC: 2429656. DOI: 10.1136/pgmj.66.778.669. View

20.

Jayne D, Davies M, Fox C, Black C, Lockwood C . Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet. 1991; 337(8750):1137-9. DOI: 10.1016/0140-6736(91)92797-6. View